These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2850311

  • 1. Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.
    Cannavò S, Li Calzi L, Aragona A, Trimarchi F.
    J Endocrinol Invest; 1988 Jun; 11(6):425-8. PubMed ID: 2850311
    [Abstract] [Full Text] [Related]

  • 2. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 3. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

  • 4. A suppressive effect of dexamethasone (DEX) on adrenocorticotropin (ACTH) response to vasoactive intestinal peptide (VIP) in Cushing's disease: a parallel modulation by DEX of ACTH responses to VIP and corticotropin-releasing hormone.
    Watanobe H, Tamura T.
    Neuropeptides; 1997 Feb; 31(1):35-40. PubMed ID: 9574835
    [Abstract] [Full Text] [Related]

  • 5. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 6. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]

  • 7. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

  • 9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 10. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]

  • 11. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 12. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [Abstract] [Full Text] [Related]

  • 13. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL.
    N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991
    [Abstract] [Full Text] [Related]

  • 14. CRH in Cushing's syndrome.
    Müller OA, Stalla GK, von Werder K.
    Horm Metab Res Suppl; 1987 Mar 08; 16():51-8. PubMed ID: 2832289
    [Abstract] [Full Text] [Related]

  • 15. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A.
    J Clin Endocrinol Metab; 1990 Mar 08; 70(3):798-803. PubMed ID: 2155255
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
    Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
    J Clin Endocrinol Metab; 1987 Jun 08; 64(6):1150-9. PubMed ID: 3033006
    [Abstract] [Full Text] [Related]

  • 17. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
    Korbonits M, Trainer PJ, Edwards R, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 1995 Jul 08; 43(1):29-35. PubMed ID: 7641409
    [Abstract] [Full Text] [Related]

  • 18. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb 08; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 19. Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
    Miljić D, Polovina S, Doknić M, Pekić S, Stojanović M, Petakov M, Micić D, Popović V.
    Neuroendocrinology; 2017 Feb 08; 104(1):33-39. PubMed ID: 26836811
    [Abstract] [Full Text] [Related]

  • 20. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK, Cutler GB, Oldfield EH, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul 08; 69(1):165-9. PubMed ID: 2543689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.